Electroencephalographic findings in COVID-19 patients: A systematic review

The spectrum of neuropathology in COVID-19

Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia

The impact of COVID-19 on epilepsy care: a survey of the American Epilepsy Society membership

COVID-19 case fatality and Parkinson’s disease

Neuro-ophthalmic manifestations of coronavirus disease 19

Risk factors for intracerebral hemorrhage in patients with COVID‐19

Multiple sclerosis and COVID‐19: how many are at risk?

Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid‐19

Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis

Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts

Stroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome studies in 8 stuporous and comatose patients

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19